VivoSeq
Psychiatry

Non-Suicidal Self-Injury (NSSI)

1

Pipeline Programs↗

1

Active Trials↗

0

Companies Involved↗

Non-suicidal Self-injury (NSSI) is an early-stage landscape with 1 program across 0 companies.

Intelligence

Pipeline Metrics

Competitive Density

14/100

Pipeline Velocity

6/100

Mech. Concentration

N/A

Completion Rate

N/A

Attrition Rate

0/100

Pipeline

Programs by Phase

Preclinical1

Treatment as Usual

AB Biotics, SA

Phase 1
No programs
Phase 2
No programs
Phase 3
No programs
Approved
No programs

Analysis

Trial Status

1

clinical trials

Not yet recruiting1 · 100%

Clinical Trials

Trial Activity

A Novel Digital Psychotherapy Intervention for Non-Suicidal Self-Injury in Adolescents: A Randomized Controlled Trial
Not yet recruiting·TThe Fourth Affiliated Hospital of Zhejiang University School of Medicine·Preclinical·NCT07683234·110 enrolled

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)